MEDI:GATE NEWS Bridge Biotherapeutics Begins Administration of Patients in Clinical Participation of BBT-176, a Next-Generation New Lung Cancer Drug Candidate
MEDI:GATE NEWS GI Innovation, Interpark Bio CEO Hong Jun-ho recruited… Attracting 20 billion investment
MEDI:GATE NEWS Antibody-based novelty novelty with a variety of potential applications, beyond SCF/c-KIT targets, we will also catch impregnable RAS
MEDI:GATE NEWS Curacle confirms efficacy and safety in Phase 2a clinical trial for new drug for diabetic nephropathy
MEDI:GATE NEWS Held a regular shareholders’ meeting of Huzel, aims to double the overseas market this year
MEDI:GATE NEWS Cheil Pharmaceuticals 14% cash dividend decision and systematic new drug development promotion
MEDI:GATE NEWS Yuhan Corporation, additionally invested 10 billion won in April Bio, listed as the 2nd largest shareholder